55 related articles for article (PubMed ID: 3499120)
1. [Cytotoxic activity of autologous lymphocytes against lung cancer cells; correlation of prognosis and recurrence pattern].
Kimura H; Yamaguchi Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2885-9. PubMed ID: 3499120
[TBL] [Abstract][Full Text] [Related]
2. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
3. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.
Fujisawa T; Yamaguchi Y
Cancer; 1997 Feb; 79(3):474-81. PubMed ID: 9028357
[TBL] [Abstract][Full Text] [Related]
4. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
5. Modality of failure following resection of stage I and stage II non-small cell lung cancer.
Ramacciato G; Paolini A; Volpino P; Aurello P; Balesh AM; D'Andrea N; Del Grande E; Passaro U; Tosato F; Fegiz G
Int Surg; 1995; 80(2):156-61. PubMed ID: 8530234
[TBL] [Abstract][Full Text] [Related]
6. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
7. [Relatively non-curative resection for lung cancer: is this a complete resection?].
Nonaka M; Kadokura M; Yamamoto S; Kataoka D; Iyano K; Kawada T; Takaba T
Kyobu Geka; 2000 Aug; 53(9):759-62. PubMed ID: 10935403
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
9. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
Kadoyama C; Kimura H; Yamaguchi Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
[TBL] [Abstract][Full Text] [Related]
11. [Cases of death after surgery for pathologic stage I non-small cell lung cancer].
Fukino S; Fukata T; Hayashi E; Okada K; Metsugi H; Miwa K; Morio S
Kyobu Geka; 2002 Feb; 55(2):110-5. PubMed ID: 11842546
[TBL] [Abstract][Full Text] [Related]
12. [Postoperative sequential testing of cytotoxic activity against the autologous and allogeneic tumor cells in patients with primary lung resected cancer].
Fujisawa T; Fukasawa T; Saitoh Y; Urabe N; Nomoto Y; Yamakawa H; Baba M; Kimura H; Yamaguchi Y
Gan No Rinsho; 1988 Nov; 34(14):1922-6. PubMed ID: 2849685
[TBL] [Abstract][Full Text] [Related]
13. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Fujisawa T; Yamaguchi Y
Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
[TBL] [Abstract][Full Text] [Related]
14. [Effect of surgical treatment on the natural killer activity in lung cancer patients].
Ancheva M; Boeva M; Tenev V
Eksp Onkol; 1989; 11(2):39-41. PubMed ID: 2737129
[TBL] [Abstract][Full Text] [Related]
15. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
16. Influence of histologic type on survival after curative resection for undifferentiated lung cancer.
Mayer JE; Ewing SL; Ophoven JJ; Sumner HW; Humphrey EW
J Thorac Cardiovasc Surg; 1982 Nov; 84(5):641-8. PubMed ID: 6290802
[TBL] [Abstract][Full Text] [Related]
17. [Immunomorphology of lymph nodes and prognosis in lung cancer].
Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
[TBL] [Abstract][Full Text] [Related]
18. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
[TBL] [Abstract][Full Text] [Related]
19. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
Kimura H; Yamaguchi Y
Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
